These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes. Kalgutkar AS, Hatch HL, Kosea F, Nguyen HT, Choo EF, McClure KF, Taylor TJ, Henne KR, Kuperman AV, Dombroski MA, Letavic MA. Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451 [Abstract] [Full Text] [Related]
5. Preclinical pharmacokinetics of a novel HIV-1 attachment inhibitor BMS-378806 and prediction of its human pharmacokinetics. Yang Z, Zadjura L, D'Arienzo C, Marino A, Santone K, Klunk L, Greene D, Lin PF, Colonno R, Wang T, Meanwell N, Hansel S. Biopharm Drug Dispos; 2005 Dec; 26(9):387-402. PubMed ID: 16142720 [Abstract] [Full Text] [Related]
9. Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studies. Prueksaritanont T, Gorham LM, Ellis JD, Fernandez-Metzler C, Deluna P, Gehret JR, Strong KL, Hochman JH, Askew BC, Duggan ME, Gilbert JD, Lin JH, Vyas KP. Drug Metab Dispos; 1996 Nov; 24(11):1263-71. PubMed ID: 8937862 [Abstract] [Full Text] [Related]
12. Pharmacokinetics and metabolism of a cysteinyl leukotriene-1 receptor antagonist from the heterocyclic chromanol series in rats: in vitro-in vivo correlation, gender-related differences, isoform identification, and comparison with metabolism in human hepatic tissue. Kuperman AV, Kalgutkar AS, Marfat A, Chambers RJ, Liston TE. Drug Metab Dispos; 2001 Nov; 29(11):1403-9. PubMed ID: 11602515 [Abstract] [Full Text] [Related]
13. Prediction of species differences (rats, dogs, humans) in the in vivo metabolic clearance of YM796 by the liver from in vitro data. Iwatsubo T, Suzuki H, Sugiyama Y. J Pharmacol Exp Ther; 1997 Nov; 283(2):462-9. PubMed ID: 9353358 [Abstract] [Full Text] [Related]
14. Hepatic and intestinal metabolism of indinavir, an HIV protease inhibitor, in rat and human microsomes. Major role of CYP3A. Chiba M, Hensleigh M, Lin JH. Biochem Pharmacol; 1997 Apr 25; 53(8):1187-95. PubMed ID: 9175724 [Abstract] [Full Text] [Related]
15. Extrapolation of diclofenac clearance from in vitro microsomal metabolism data: role of acyl glucuronidation and sequential oxidative metabolism of the acyl glucuronide. Kumar S, Samuel K, Subramanian R, Braun MP, Stearns RA, Chiu SH, Evans DC, Baillie TA. J Pharmacol Exp Ther; 2002 Dec 25; 303(3):969-78. PubMed ID: 12438516 [Abstract] [Full Text] [Related]